Frazier Healthcare Partners
Frazier Healthcare Partners is a Seattle- and New York-based investment firm, founded in 1991, focused on healthcare services, medical devices, pharmaceutical services, and biopharmaceuticals. The firm pursues growth buyout investments in profitable U.S. middle-market healthcare businesses and equity investments in private and public life sciences companies. Frazier pairs thematic, thesis-driven investing with an Executive-in-Residence program and an internal Center of Excellence that provides functional operating support across M&A, commercial strategy, human capital, data & AI, technology, and finance/operations.
Frazier Healthcare Partners
Services
Growth Buyout Investments
Equity investments and buyouts in profitable U.S. middle-market healthcare businesses, often establishing platform companies and pursuing add-on acquisitions.
Life Sciences & Biopharmaceutical Investments
Equity investments in private and public companies developing and commercializing biopharmaceuticals and related life sciences businesses.
Executive-in-Residence (EIR) Program
Engages senior industry executives to support investment theses, lead platform companies, and accelerate operational execution.
Center of Excellence (CoE) — Functional Operating Support
In-house multidisciplinary team providing expertise across finance & operations, commercial strategy & marketing, human capital, data & AI, technology & project management, and M&A integration to support value-creation programs and post-close integrations.
Mergers & Acquisitions and Integration Support
Transaction execution support and integration management led by deal teams and CoE partners to capture synergies for platform and add-on acquisitions.
Commercial Strategy & Marketing
Go-to-market strategy, customer segmentation, demand generation, sales force effectiveness, and product launch support provided to portfolio companies.
Growth Buyout Investments
Equity investments and buyouts in profitable U.S. middle-market healthcare businesses, often establishing platform companies and pursuing add-on acquisitions.
Life Sciences & Biopharmaceutical Investments
Equity investments in private and public companies developing and commercializing biopharmaceuticals and related life sciences businesses.
Executive-in-Residence (EIR) Program
Engages senior industry executives to support investment theses, lead platform companies, and accelerate operational execution.
Center of Excellence (CoE) — Functional Operating Support
In-house multidisciplinary team providing expertise across finance & operations, commercial strategy & marketing, human capital, data & AI, technology & project management, and M&A integration to support value-creation programs and post-close integrations.
Mergers & Acquisitions and Integration Support
Transaction execution support and integration management led by deal teams and CoE partners to capture synergies for platform and add-on acquisitions.
Commercial Strategy & Marketing
Go-to-market strategy, customer segmentation, demand generation, sales force effectiveness, and product launch support provided to portfolio companies.
Portfolio
Leading global manufacturer of branded and private-label anesthesia and respiratory products; locations in U.S., Mexico and China; serves 6,000+ hospitals and ASCs in 80+ countries. Products include oxygen delivery, circuits, capnography, medication delivery, sterile water, and pressure infusion products. Location: Grand Rapids, Michigan. Year of investment: listed on firm portfolio page.
#Medical devices — anesthesia and respiratory products
Provides nationwide specialty infusion pharmacy services with clinical focus in neurology, immunology and blood disorders; serves patients across 50 states and partners with over 2,500 physician referral relationships. Location: Plantation, Florida. Year of investment: 2024.
#Home infusion / specialty pharmacy services
Provider of cold chain shipping solutions for biologics, cell & gene therapies and vaccines; headquartered in Monroe, Ohio; listed year of Frazier investment: 2020; Frazier acquired a stake in 2021 per announcements.
#Cold chain logistics (temperature-controlled shipping for life sciences)
Independent provider of aftermarket parts and component repairs for MRI, CT and other imaging modalities; serves independent service organizations, OEMs, and healthcare providers. Location: Poway, California. Year of investment: 2024.
#Imaging parts and component repairs (diagnostic imaging aftermarket)
Provides real-time data and insights to life sciences organizations via a proprietary network of healthcare providers; formed through combination of market research businesses. Location: Watertown, Massachusetts. Year of investment: 2022.
#Real-time data and market insights (healthcare & life sciences insights)
Provider of commercialization and supply chain solutions including Marketing & Sample Management, third-party logistics, and custom pharmacy solutions. Headquartered in Lakewood, New Jersey. Year of investment: 2025.
#Commercialization services for pharma, biotech and medtech (MSM, 3PL, custom pharmacy)
Leading global manufacturer of branded and private-label anesthesia and respiratory products; locations in U.S., Mexico and China; serves 6,000+ hospitals and ASCs in 80+ countries. Products include oxygen delivery, circuits, capnography, medication delivery, sterile water, and pressure infusion products. Location: Grand Rapids, Michigan. Year of investment: listed on firm portfolio page.
#Medical devices — anesthesia and respiratory products
Provides nationwide specialty infusion pharmacy services with clinical focus in neurology, immunology and blood disorders; serves patients across 50 states and partners with over 2,500 physician referral relationships. Location: Plantation, Florida. Year of investment: 2024.
#Home infusion / specialty pharmacy services
Provider of cold chain shipping solutions for biologics, cell & gene therapies and vaccines; headquartered in Monroe, Ohio; listed year of Frazier investment: 2020; Frazier acquired a stake in 2021 per announcements.
#Cold chain logistics (temperature-controlled shipping for life sciences)
Independent provider of aftermarket parts and component repairs for MRI, CT and other imaging modalities; serves independent service organizations, OEMs, and healthcare providers. Location: Poway, California. Year of investment: 2024.
#Imaging parts and component repairs (diagnostic imaging aftermarket)
Provides real-time data and insights to life sciences organizations via a proprietary network of healthcare providers; formed through combination of market research businesses. Location: Watertown, Massachusetts. Year of investment: 2022.
#Real-time data and market insights (healthcare & life sciences insights)
Provider of commercialization and supply chain solutions including Marketing & Sample Management, third-party logistics, and custom pharmacy solutions. Headquartered in Lakewood, New Jersey. Year of investment: 2025.
#Commercialization services for pharma, biotech and medtech (MSM, 3PL, custom pharmacy)